Ganowa a Lokaci guda don Kamuwa da Tarin Fuka da kuma Juriyar RIF & NIH

Tarin fuka (TB), wanda tarin fuka na Mycobacterium ke haifarwa, ya kasance barazana ga lafiyar duniya. Kuma karuwar juriya ga magungunan tarin fuka masu mahimmanci kamar Rifampicin (RIF) da Isoniazid (INH) babban cikas ne ga kokarin shawo kan tarin fuka na duniya. WHO ta ba da shawarar gwajin kwayoyin cuta cikin sauri da daidaito na tarin fuka da kuma juriya ga RIF&INH don gano marasa lafiya da suka kamu da cutar kan lokaci da kuma samar musu da magani mai dacewa cikin lokaci.

Kalubale

Kimanin mutane miliyan 10.6 ne suka kamu da cutar tarin fuka a shekarar 2021, inda aka samu karuwar kashi 4.5% daga miliyan 10.1 a shekarar 2020, wanda ya yi sanadiyyar mutuwar mutane miliyan 1.3, daidai da mutane 133 a cikin mutum 100,000.

Tarin fuka mai jure wa magunguna, musamman MDR-TB (mai jure wa RIF & INH), yana ƙara yin tasiri ga maganin tarin fuka da rigakafinsa a duniya.

Ana buƙatar gaggawa wajen gano cutar tarin fuka da kuma juriyar RIF/INH a lokaci guda don samun magani da wuri kuma mafi inganci idan aka kwatanta da jinkirin sakamakon gwajin kamuwa da cutar.

Maganinmu

Gano Tarin Fuka na Marco & Micro Test guda 3-a cikin 1 don kamuwa da cutar tarin fuka/Gano Tarin Fuka da Tarin Fuka na RIF & NIH Kityana ba da damar gano cutar tarin fuka da RIF/INH cikin inganci a cikin ganowa ɗaya.

Fasahar Melting Curve tana gano tarin fuka da kuma tarin fuka a lokaci guda.

Gano tarin fuka/TB guda 3 a cikin 1 da ke tantance kamuwa da cutar tarin fuka da kuma juriyar maganin farko (RIF/INH) yana ba da damar yin maganin tarin fuka cikin lokaci da kuma daidai.

Mycobacterium Tuberculosis Nucleic Acid da Rifampicin, Kayan Gano Juriya na Isoniazid (Narkewar Lanƙwasa)

Na yi nasarar gano gwajin tarin fuka sau uku (cutar tarin fuka, RIF & juriyar NIH) a cikin ganowa ɗaya!

Mai Saurisakamako:Akwai a cikin awanni 1.5-2 tare da fassarar sakamako ta atomatik yana rage horon fasaha don aiki;

Samfurin Gwaji:1-3 mL na maniyyi;

Babban Jin Daɗi:Nazari kan yadda ƙwayoyin cuta 50/mL ke shafar tarin fuka da 2x10³ƙwayoyin cuta/mL ga ƙwayoyin cuta masu jure wa RIF/INH, yana tabbatar da ingantaccen ganowa koda a ƙananan nauyin ƙwayoyin cuta.

Manufa Da Yawas: TB-IS6110; juriyar RIF-rpoB (507~503);

juriyar INH-InhA/AhpC/katG 315;

Tabbatar da Inganci:Sarrafa ƙwayoyin halitta don tabbatar da ingancin samfurin don rage rashin gaskiya;

Daidatuwa Mai Faɗi: Daidaituwa da yawancin tsarin PCR na yau da kullun don samun damar dakin gwaje-gwaje mai faɗi;

Bin Dokokin WHO: Bin ƙa'idodin WHO game da kula da tarin fuka masu jure wa magunguna, tabbatar da aminci da dacewa a aikin asibiti.